Document:

Exhibit
10.2

 

AVAYA
INC. 2004 LONG TERM INCENTIVE PLAN

as amended effective

May 3, 2007

AVAYA INC. 2004 LONG TERM
INCENTIVE PLAN

Article 1 — Background and Purpose

This is the amended and
restated Avaya Inc. Long Term Incentive Plan for Management Employees (the “Prior
Plan”), which, among other things, has been amended and restated to include
provisions relating to Awards to Non-Employee Directors.  Pursuant to the terms of this document, this
amended and restated plan shall be called the Avaya Inc. 2004 Long Term
Incentive Plan.

The purpose of this Plan
is to enhance shareholder value by reinforcing the Company’s efforts to
motivate Employees to contribute to the Company’s growth and performance and
enabling the Company to attract and retain individuals of exceptional
managerial talent upon whom, in large measure, the sustained progress, growth
and profitability of the Company depend. 
In addition, the Plan is designed to
attract and retain qualified persons to serve as directors, to enhance the
equity interest of directors in the Company, and to solidify the common
interests of its directors and shareholders in enhancing the value of the
Company’s common stock.  The Plan seeks
to encourage the highest level of director performance by providing directors
with a proprietary interest in the Company’s performance and progress.

Article 2 — Definitions

For the purposes of this
Plan, the following words shall have the meanings ascribed to them below:

(a)                                  Affiliate

Any
(i) Person that directly or through one or more intermediaries, controls, or is
controlled by, or is under common control with, the Company or (ii) entity in
which the Company has a significant equity interest, as determined by the
Committee.

(b)                                  Annual
Meeting

The
Company’s annual, general meeting of shareholders.

(c)                                  Annual
Term

Each
twelve calendar-month period beginning on March 1, 2004 and each March 1
thereafter.

(d)                                  Award

Any Option, Stock
Appreciation Right, Restricted Stock Award, Performance Award, Dividend
Equivalent, Other Stock Unit Award, Substitute Award, Stock Retainer or any
other right, interest, or option relating to Shares or other securities of the
Company granted pursuant to the provisions of the Plan.

	
  (e)

  	
  Award Agreement

  
	
   

  	
   

  
	
   

  	
  The written agreement, contract or other instrument
  or document provided by the Company to evidence an Award and signed by both
  the Company and the Participant, or such other documentation in such form as
  the Committee may from time to time approve.

  
	
   

  	
   

  
	
  (f)

  	
  Board

  
	
   

  	
   

  
	
   

  	
  The Board of Directors of the Company.

  
	
   

  	
   

  
	
  (g)

  	
  Business Day

  
	
   

  	
   

  
	
   

  	
  Any day on which the New York Stock Exchange is open
  for transaction of business.

  
	
   

  	
   

  
	
  (h)

  	
  Change in Control

  
	
   

  	
   

  
	
   

  	
  The happening of any of the following events:

  

 

(i) An acquisition by any individual, entity or group
(within the meaning of Section 13 (d)(3) or 14 (d)(2) of the Exchange Act) (an “Entity”)
of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of 50% or more of either (A) the then outstanding shares of
common stock of the Company (the “Outstanding Company Common Stock”) or (B) the
combined voting power of the then outstanding voting securities of the Company
entitled to vote generally in the election of directors (the “Outstanding
Company Voting Securities”); excluding, however, the following: (1) any
acquisition directly from the Company, other than an acquisition by virtue of
the exercise of a conversion privilege unless the security so being converted
was itself acquired directly from the Company, (2) any acquisition by the
Company, (3) any acquisition by any employee benefit plan (or related trust)
sponsored or maintained by the Company or any corporation controlled by the
Company, or (4) any acquisition by any corporation pursuant to a transaction
which complies with clauses (A), (B) and (C) of subsection (iii) of this
Article 2(g); or

(ii) A change in the composition of the Board such
that the individuals who, as of the Effective Date, constitute the Board (such
Board shall be hereinafter referred to as the “Incumbent Board”) cease for any
reason  to constitute at least a majority
of the Board; provided, however, that for purposes of this
definition, any individual who becomes a member of the Board subsequent to the
Effective Date, whose election, or nomination for election by the Company’s
stockholders, was approved by a vote of at least a majority of those
individuals who are members of the Board and who were also members of the
Incumbent Board (or deemed to be such pursuant to this proviso) shall be
considered as though such individual were a member of the Incumbent Board; and provided,
further  however, that any such individual whose initial
assumption of office occurs as a result of or in connection with either an
actual or threatened election contest 

 3
 

(as such terms are used in Rule 14a-11 of Regulation 14A promulgated
under the Exchange Act) or other actual or threatened solicitation of proxies
or consents by or on behalf of an Entity other than the Board shall not be so
considered as a member of the Incumbent Board; or

(iii) The approval by the stockholders of the Company
of a merger, reorganization or consolidation or sale or other disposition of
all or substantially all of the assets of the Company (each, a “Corporate
Transaction”) or, if consummation of such Corporate Transaction is subject, at
the time of such approval by stockholders, to the consent of any government or
governmental agency, the obtaining of such consent (either explicitly or
implicitly by consummation); excluding however, such a Corporate Transaction
pursuant to which (A) all or substantially all of the individuals and entities
who are beneficial owners, respectively, of the Outstanding Company Stock and Outstanding
Company Voting Securities immediately prior to such Corporate Transaction will
beneficially own, directly or indirectly, more than 60% of, respectively, the
outstanding shares of common stock, and the combined voting power of the then
outstanding voting securities entitled to vote generally in the election of
directors, as the case may be, of the corporation resulting from such Corporate
Transaction (including, without limitation, a corporation or other Person which
as a result of such transaction owns the Company or all or substantially all of
the Company’s assets either directly or through one or more subsidiaries (a “Parent
Company”)) in substantially the same proportions as their ownership,
immediately prior to such Corporate Transaction, of the Outstanding Company
Common Stock and Outstanding Company Voting Securities, as the case may be, (B)
no Entity (other than the Company, any employee benefit plan (or related trust)
of the Company, such corporation resulting from such Corporate Transaction or,
if reference was made to equity ownership of any Parent Company for purposes of
determining whether clause (A) above is satisfied in connection with the
applicable Corporate Transaction, such Parent Company) will beneficially own,
directly or indirectly, 50% or more of, respectively, the outstanding shares of
common stock of the corporation resulting from such Corporate Transaction or
the combined voting power of the outstanding voting securities of such
corporation entitled to vote generally in the election of the directors unless
such ownership resulted solely from ownership of securities of the Company
prior to the Corporate Transaction, and (C) individuals who were members of the
Incumbent Board will immediately after the consummation of the Corporate
Transaction constitute at least a majority of the members of the board of
directors of the corporation resulting from such Corporate Transaction (or, if
reference was made to equity ownership of any Parent Company for purposes of
determining whether clause (A) above is satisfied in connection with the
applicable Corporate Transaction, of the Parent Company); or

(iv)  The approval by the stockholders of
the Company of a complete liquidation or dissolution of the Company.

(i)            Code

The Internal
Revenue Code of 1986, as amended.

 4
 

 

	
  (j)

  	
  Committee

  
	
   

  	
   

  
	
   

  	
  The Corporate Governance and Compensation Committee
  of the Board, or any successor committee that is comprised of two or more
  Directors who meet the criteria for independence as required by any
  applicable law and the listing standards of the New York Stock Exchange.

  
	
   

  	
   

  
	
  (k)

  	
  Company

  
	
   

  	
   

  
	
   

  	
  Avaya Inc., a Delaware corporation.

  
	
   

  	
   

  
	
  (l)

  	
  Company Action

  
	
   

  	
   

  
	
   

  	
  A Company or
  Subsidiary declared or initiated (i) termination from service under a
  force management program, (ii) sale of a unit or portion of a unit,
  (iii) transfer of a Participant to a corporation, partnership, limited
  liability company or other business entity in which the Company has a direct
  or indirect equity interest and which does not constitute a Subsidiary or
  (iv) placement of the job function of a Participant with an outsourcing
  contractor unless the successor employer has made appropriate provision for
  the assumption and continuation of Awards of Employees who are employed by the
  successor employer after an event described in (ii), (iii) or (iv).

  
	
   

  	
   

  
	
  (m)

  	
  Covered Employee

  
	
   

  	
   

  
	
   

  	
  The Chief Executive Officer and all Vice-Presidents.

  
	
   

  	
   

  
	
  (n)

  	
  Deferral Plan

  
	
   

  	
   

  
	
   

  	
  The Company’s Deferred Compensation Plan, and any
  successor or replacement plan then in effect with respect to Participants.

  
	
   

  	
   

  
	
  (o)

  	
  Delegate

  
	
   

  	
   

  
	
   

  	
  The person or committee authorized by the Committee
  or the Board to exercise specified authority under this Plan.

  
	
   

  	
   

  
	
  (p)

  	
  Dividend Equivalent

  
	
   

  	
   

  
	
   

  	
  Has the meaning assigned in Article 6(b).

  

 

 5
 

 

	
  (q)

  	
  Disability or Disabled

  
	
   

  	
   

  
	
  

  	
  Termination of employment under circumstances where
  the Participant qualifies for benefits under a long-term disability pay plan
  as provided in the Participant’s Award Agreement.

  
	
   

  	
   

  
	
  (r)

  	
  Discounted Option

  
	
   

  	
   

  
	
   

  	
  Any Option awarded under Article 7 with an exercise
  price that is less than the Fair Market Value of a Share on the date of the
  grant.

  
	
   

  	
   

  
	
  (s)

  	
  Effective Date

  
	
   

  	
   

  
	
   

  	
  See Article 21.

  
	
   

  	
   

  
	
  (t)

  	
  Employee

  
	
   

  	
   

  
	
   

  	
  Any employee of the Company or any Subsidiary,
  excluding leased employees within the meaning of Section 414(n) of the Code.

  
	
   

  	
   

  
	
  (u)

  	
  Exchange Act

  
	
   

  	
   

  
	
   

  	
  The Securities Exchange Act of 1934, as amended.

  
	
   

  	
   

  
	
  (v)

  	
  Exercise Date

  
	
   

  	
   

  
	
   

  	
  See Article 19(c)(v).

  
	
   

  	
   

  
	
  (w)

  	
  Existing Plans

  
	
   

  	
   

  
	
   

  	
  The Prior Plan, the 2000 Long Term Incentive Plan,
  the 2000 Stock Compensation Plan for Non-Employee Directors and the
  Broad-Based Stock Option Plan.

  
	
   

  	
   

  
	
  (x)

  	
  Expiration Date

  
	
   

  	
   

  
	
  .

  	
  The date specified in the Award Agreement after
  which rights under the Award expire

  
	
   

  	
   

  
	
  (y)

  	
  Fair Market Value

  
	
   

  	
   

  
	
   

  	
  The average of the high and low sales prices of a
  Share as reported on the New York Stock Exchange on the Grant Date, or if no
  sales of Shares were reported on such date, the average of the high and low
  sales prices of a Share on the next preceding day on which sales were
  reported.

  

 

 6
 

 

	
  (z)

  	
  Grant Date

  
	
   

  	
   

  
	
  

  	
  The Grant Date shall be the date an Award is granted
  as set forth in the Award Agreement.

  
	
   

  	
   

  
	
  (aa)

  	
  Net Income

  
	
   

  	
   

  
	
   

  	
  The net income of the Company as determined under
  generally accepted accounting principles, excluding (a) extraordinary items
  (net of applicable taxes); (b) cumulative effects of changes in accounting
  principles; (c) gains and losses (net of applicable taxes) from the sales of
  securities; and (d) nonrecurring items (net of applicable taxes) including,
  but not limited to, gains or losses on asset dispositions and sales of
  divisions, business units or subsidiaries, restructuring charges, gains and
  losses from qualified benefit plan curtailments and settlements, and income
  or expenses related to deferred tax assets.

  
	
   

  	
   

  
	
   (bb)

  	
  Non-Employee Director

  
	
   

  	
   

  
	
   

  	
  A member of the
  Board who is not an Employee of the Company or any of its Affiliates.

  
	
   

  	
   

  
	
  (cc)

  	
  Option

  
	
   

  	
   

  
	
   

  	
  An Award described in Article 7.

  
	
   

  	
   

  
	
  (dd)

  	
  Other Stock Unit Award

  
	
   

  	
   

  
	
   

  	
  An Award described in Article 11.

  
	
   

  	
   

  
	
  (ee)

  	
  Participant

  
	
   

  	
   

  
	
   

  	
  Each (i) Employee or (ii) Non-Employee Director, who
  is selected by the Committee to receive an Award under the Plan

  
	
   

  	
   

  
	
  (ff)

  	
  Performance Award

  
	
   

  	
   

  
	
   

  	
  An award described in Article 10.

  
	
   

  	
   

  
	
  (gg)

  	
  Performance Period

  
	
   

  	
   

  
	
   

  	
  That period, established by the Committee at or
  after the time any Performance Award is granted, during which any performance
  goals specified by the Committee with respect to such Award are to be
  measured.

  

 

 7
 

 

	
  (hh)

  	
  Person

  
	
   

  	
   

  
	
  

  	
  Any individual, corporation, partnership,
  association, joint-stock company, trust, unincorporated organization, limited
  liability company, other entity or government or political subdivision.

  
	
   

  	
   

  
	
  (ii)

  	
  Plan

  
	
   

  	
   

  
	
   

  	
  The Avaya Inc. 2004 Long Term Incentive Plan
  (formerly known as the Long Term Incentive Plan for Management Employees).

  
	
   

  	
   

  
	
  (jj)

  	
  Restricted Stock

  
	
   

  	
   

  
	
   

  	
  An Award described in Article 9.

  
	
   

  	
   

  
	
  (kk)

  	
  Retainer

  
	
   

  	
   

  
	
   

  	
  The retainer paid to a Non-Employee Director as
  compensation for services as a member of the Board or any committee of the
  Board with respect to each Annual Term, but shall not include any
  reimbursement for expenses.

  
	
   

  	
   

  
	
  (ll)

  	
  Retirement

  
	
   

  	
   

  
	
   

  	
  Termination of the employment of an Employee with
  the Company or any Subsidiary under circumstances where the Employee
  qualifies for benefits under a retirement plan as provided in the Employee’s
  Award Agreement.

  
	
   

  	
   

  
	
  (mm)

  	
  Share

  
	
   

  	
   

  
	
   

  	
  A share of the common stock of the Company, par
  value $.01 per share.

  
	
   

  	
   

  
	
  (nn)

  	
  Stock Appreciation Right

  
	
   

  	
   

  
	
   

  	
  An Award described in Article 8.

  
	
   

  	
   

  
	
  (oo)

  	
  Stock Award Committee

  
	
   

  	
   

  
	
   

  	
  A committee of one or more directors appointed by
  the Committee pursuant to Article 4.

  
	
   

  	
   

  
	
  (pp)

  	
  Stock Retainer

  
	
   

  	
   

  
	
   

  	
  That portion of a Non-Employee Director’s Retainer
  that, pursuant to Article 19(a) of this Plan, such Non-Employee Director has
  elected, or is required, to receive in Shares.

  

 

 8

(qq)         Subsidiary

 

A “subsidiary corporation”
of the Company as defined in Section 424(f) of the Code, an entity in which the
Company directly or indirectly owns 50% or more of the voting interests or an
entity in which the Company has a significant equity interest, as determined by
the Committee.

(rr)         Substitute Award

An Award granted in lieu
of an Option, Restricted Stock or Stock Appreciation Right pursuant to Article
17.

(ss)         Term

The period beginning on
the date this Plan is approved by the stockholders of the Company, and ending
on October 1, 2013.

Article 3 — Shares Available for Awards;
Adjustments

(a)  Subject to adjustment as provided in Article
3(b) and the remainder of this Article 3(a), the aggregate number of Shares
which may be made subject to Awards granted under this Plan shall not exceed
29,000,000; provided, however, that from and after February 15, 2007, such
number shall be increased to 55,000,000. 
Any Shares granted as Options (other than Discounted Options) or Stock
Appreciation Rights shall be counted against this limit as one (1) Share for
every one (1) Share granted.  Any Shares
granted as Awards other than Options or Stock Appreciation Rights shall be
counted against this limit as one and thirty-five hundredths (1.35) Share for
every one (1) Share granted. For each Discounted Option granted, the number of
full Shares representing the aggregate value of the discount on the date of
grant shall reduce the number of Shares that may be available for the grant of
Awards by one and thirty-five hundredths (1.35) Share for every one (1) Share
granted.  If any Shares are subject to an
Award, including an award under any of the Existing Plans that was made prior
to and remains outstanding as of the Effective Date, that is forfeited, settled
in cash, expires, or is otherwise terminated without issuance of Shares, such
Shares shall again be available for Awards under the Plan if no Participant
shall have received any benefits of ownership in respect thereof.  In addition, the number of shares available
for Awards under the Plan shall be increased by (i) that number of Shares which
the Company repurchases in the open market or otherwise with proceeds received
from Option exercises, (ii) Shares that are tendered or withheld to pay the
exercise or purchase price of an Award or to settle tax withholding or other
obligations arising in connection with an Award, and (iii) Shares that are not
otherwise issued pursuant to an Award, in each case including with respect to
awards made under any of the Existing Plans prior to and remaining outstanding
as of the Effective Date.  In addition,
the number of Shares available for grants under the Plan or to a Participant in
any fiscal year shall not be reduced by Awards granted or Shares issued by the
Company through the assumption of, or in substitution or exchange for awards or
the right or obligation to make future grants of awards in connection with the
acquisition of another corporation or business entity.  Any Shares issued under the Plan may consist,
in whole or in part, of authorized and unissued Shares, Shares purchased in 

 9
 

the open market or
otherwise, treasury Shares, or any combination of the foregoing, as the Board
or the Committee may from time to time determine.

(b)   (i) In the event of any Business Combination (as such term is
defined under accounting principles generally accepted in the United States (“GAAP”)),
such adjustments and other substitutions shall be made to the Plan and each
outstanding Award as the Committee in its sole discretion deems equitable or
appropriate, including, without limitation: such adjustments in the aggregate
number, class and kind of Shares or other consideration which may be delivered
under the Plan, in the aggregate or to any one Participant; in the number,
class, kind and option or exercise price of Shares subject to outstanding
Awards granted under the Plan; and in the number, class and kind of Shares
subject to Awards granted under the Plan (including, if the Committee deems
appropriate, the substitution of similar options to purchase the shares of, or
other awards denominated in the shares of, another company).

(ii)    In the event of any Equity Restructuring (as such term is defined
under GAAP),  the Committee shall be
required to make an equitable adjustment to the Shares subject to this Plan and
each outstanding Award, including, without limitation: adjusting the aggregate
number, class and kind of Shares or other consideration which may be delivered
under the Plan; adjusting the number, class, kind and option or exercise price
of Shares subject to outstanding Awards granted under the Plan; and adjusting
the number, class and kind of Shares subject to Awards granted under the Plan
(including, the substitution of similar options to purchase the shares of, or
other awards denominated in the shares of, another company).

After any adjustment under
this paragraph (b), the number of Shares or other securities subject to any
Award shall always be a whole number.

(c)  Except as provided in Article 22, the
Committee shall be authorized to make adjustments in Performance Award criteria
or in the terms and conditions of other Awards in recognition of unusual or
nonrecurring events affecting the Company or its financial statements, or
changes in applicable laws, regulations or accounting principles.  The Committee may correct any defect, supply
any omission or reconcile any inconsistency in the Plan or any Award in the
manner and to the extent it shall deem desirable.  In the event the Company shall assume
outstanding employee benefit awards or the right or obligation to make future
such awards in connection with the acquisition of another corporation or
business entity, the Committee may, in its discretion, make such adjustments in
the terms of Awards under the Plan as it shall deem appropriate.

Article 4 — Administration

The Plan shall be
administered by the Committee.  The Committee shall have full power and
authority, subject to such resolutions not inconsistent with the provisions of
the Plan as may from time to time be adopted by the Board, to (i) interpret and
administer the Plan and any instrument or agreement entered into under the
Plan; (ii) establish such rules and regulations and appoint such agents as it
shall deem appropriate for the proper administration and interpretation of the
Plan, including a Stock Award Committee to make grants of Awards and 

 10
 

discharge the duties of the Committee; and (iii) make any other
determination and take any other action that the Committee deems necessary or
desirable for administration of the Plan. 
The Committee or the Stock Award Committee may appoint a Delegate
to administer and interpret the provisions of the Plan, promulgate rules and
regulations under the Plan, discharge the duties of the Committee under
Articles 12 and 17, designate employees to perform ministerial functions under
this Plan and execute documents on behalf of the Company; provided, however,
that any Delegate appointed pursuant to this Article 4 who is a Participant in
the Plan shall not participate in making any decision that would benefit such
Delegate, except to the extent such decision would only incidentally benefit
the Delegate and would also generally benefit a larger class of Participants.

The interpretations and
construction of any provision of the Plan by the Committee, the Stock Award
Committee, or the Delegate, as the case may be, as well as any factual
determinations, shall be final, unless otherwise determined by the Board.  No member of the Board, the Committee, the
Stock Award Committee or any Delegate shall be liable for any action or
determination made by him or her in good faith.

Article 5 — Eligibility

The Committee, in its
sole discretion, may grant an Award to (i) any Employee who is actively
employed by the Company or a Subsidiary and (ii) to any Non-Employee
Director.  The adoption of this Plan
shall not be deemed to give any Employee or Non-Employee Director any right to
be granted an Award, except and to the extent and upon such terms and
conditions as may be determined by the Committee.

Article 6 — Awards — General

(a)  Awards may be granted to Participants either
alone, in tandem with or in addition to any other type of Award granted under
the Plan.  Awards may be granted for no
consideration, for such minimum consideration as is required by applicable law
or for such other consideration as the Committee may determine.  Any Award granted under the Plan shall be
evidenced by an Award Agreement.  The
prospective recipient of any Award shall not, with respect to such Award, be
deemed to have become a Participant, or to have any rights with respect to such
Award, until and unless such recipient has complied with the then applicable
terms and conditions of the related Award Agreement.  The term of each Award shall be for such
period of months or years from date of its grant as may be determined by the
Committee; provided  that in no event shall the term of any Option
exceed a period of seven (7) years from its Grant Date.  The Committee may impose such conditions on
the exercise or vesting of any Award as it shall deem appropriate.

(b)  Subject to the provisions of this Plan and
any Award Agreement, the recipient of an Award (including, without limitation,
any deferred award) may, if so determined by the Committee, be entitled to
receive, currently or on a deferred basis, interest or dividends, or interest
or dividend equivalents (collectively, “Dividend Equivalents”), with respect to
the number of Shares covered 

 11
 

by the Award, as
determined by the Committee, in its sole discretion, and the Committee may
provide that such amounts (if any) shall be deemed to have been reinvested in
additional Shares or otherwise reinvested.

Article 7
— Options

An Option is a right to
purchase Shares subject to the following terms and conditions and to such
additional terms and conditions, not inconsistent with the provisions of the
Plan, as the Committee shall deem desirable; provided, however, that in no
event shall any Option granted under this Plan be an “incentive stock option”
as such term is defined under Section 422 of the Code:

(a)  Option Price.  The exercise price per Share under an Option
shall be determined by the Committee in its sole discretion; provided  that
such exercise price shall not be less than 75% of the Fair Market Value of a
Share on the date of the grant.

(b)  Exercisability.  Options shall be exercisable at such time or
times as determined by the Committee at or subsequent to grant.

(c)  Method Of Exercise.  Subject to the other provisions of the Plan
and any applicable Award Agreement, any Option may be exercised by the
Participant in whole or in part at such time or times, and the Participant may
make payment of the option price in such form or forms, including, without
limitation, payment by delivery of cash or Shares (whether through actual
delivery or attestation of sufficient ownership)  or by any combination of cash or Shares.  Subject to the other provisions of the Plan
and any applicable Award Agreement, if permitted by the Committee, applicable
accounting rules and applicable law, the Company may withhold Shares as payment
of the exercise price for any Option.

(d)  Form Of Settlement.  In its sole discretion, the Committee may
provide, at the time of grant, that the Shares to be issued upon an Option’s
exercise shall be in the form of Restricted Stock or other similar securities,
or may reserve the right so to provide after the time of grant.

(e)  Repricing.  Any repricing (as such term is defined under
the listing standards of the New York Stock Exchange) of Options that are
granted pursuant to the terms of this Plan shall be subject to the approval of
the Company’s shareholders.

Article 8 — Stock Appreciation Rights

A Stock Appreciation
Right is a right to receive in cash the difference between the Fair Market
Value of a Share on the exercise date and the Grant Date.  Stock Appreciation Rights may be granted
alone (“freestanding”) or may be related to an Option or other Award.  A freestanding Stock Appreciation Right shall
otherwise have the same terms and conditions as an Option.  Any Stock Appreciation Right related to an
Option may be granted at the same time such Option is granted or at any time
thereafter before exercise or expiration of such Option.  In the case of any Stock Appreciation Right
related to any Op­tion, the Stock Appreciation Right or 

 12
 

applicable portion
thereof shall terminate and no longer be exercisable upon the termination or
exer­cise of the related Option, ex­cept that a Stock Appreciation Right
granted with respect to less than the full num­ber of Shares covered by a
related Option shall not be reduced until the exercise or termination of the
related Option exceeds the number of Shares not cov­ered by the Stock
Appreciation Right.  Any Option related
to any Stock Appreciation Right shall no longer be exercisable to the extent
the related Stock Appreciation Right has been exercised.

Article 9 — Restricted Stock

Restricted Stock is an
Award in the form of Shares issued with the restriction that the Participant
may not sell, transfer, pledge or assign the Shares and with any other restrictions
that the Committee may impose (including restrictions on the right to vote or
receive cash dividends on the Shares) which restrictions may lapse separately
or in combination at such time or times, in installments or otherwise, as the
Committee shall determine.

Article 10 — Performance Awards

A Performance Award is an
Award of Performance Units or Performance Shares which vests and becomes
non-forfeitable based on performance criteria determined by the Committee to be
achieved over a prescribed Performance Period. 
An Award of Performance Shares is a number of units valued by reference
to a designated number of Shares, and an Award of Performance Units is a number
of units valued by reference to a designated amount of property other than
Shares.  The performance criteria to be
achieved during any Performance Period and the length of the Performance Period
shall be determined by the Committee upon the grant of each Performance
Award.  Except as provided in Articles 12
and 14, Performance Awards will be distributed only after the end of the rele­vant
Performance Period.  A Performance Period
shall not be less than twelve months nor greater than five years.

Performance Awards may be
paid in cash, Shares, other property or any combination of the foregoing, in
the sole discre­tion of the Committee upon the grant of the Performance
Award.  The performance levels which have
been achieved for each Performance Period and the amount of the Award to be
distributed shall be conclu­sively deter­mined by the Committee.  Performance Awards may be paid in a lump sum
or in installments following the close of the Performance Period.

Article
11 — Other Stock Unit Awards

Other Awards of Shares
and other Awards that are valued in whole or in part by reference to, or are otherwise
based on, Shares (“Other Stock Unit Awards”) may be paid in Shares, other
securities of the Company, cash or any other form of property as the Committee
shall determine upon the grant of the Other Stock Unit Award.  Other Stock Unit Awards may be issued with
such restrictions that the Committee may impose, which restrictions may lapse
separately or in combination at such time or times, in installments or
otherwise, as the Committee shall determine. 
Shares purchased pursuant to Other Stock Unit Awards shall be 

 13
 

purchased for such
consideration as the Committee shall in its sole discretion determine, which
shall not be less than the Fair Market Value of such Shares as of the Grant
Date of such Award.

Article 12 —Termination of Employment

Except as otherwise
provided in Article 19 or in an Award Agreement, the provisions of this Article
12 shall govern the rights of Participants to exercise Options following
termination of employment.  If a
Participant terminates employment for any reason other than Retirement,
Disability or death (i) any portion of the Participant’s Options which are
exercisable on the date employment terminates may be exercised until the
earlier of ninety days following termination of employment or the original
Expiration Date of the Option, and (ii) any portion of an Option that is not
exercisable on the date employment terminates shall be forfeited and canceled,
except that if the reason for the termination of employment is a Company
Action, then the Option shall become immediately exercisable for the period
specified in clause (i) with respect to the number of Shares determined by the
following formula, and shall be forfeited and canceled with respect to the
remaining Shares:

	
  Shares

  	
   

  	
   

  	
   Original Shares

  	
   

  	
   

  	
   

  	
  Number of
  Completed Months Prior to

  	
   

  	
   

  
	
  Exercisable 

  =

  	
   

  	
   

  	
   Granted

  	
   

  	
  X

  	
   

  	
  Termination of
  Employment Since 

  Granted

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Number of Complete Months from Grant 

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Date to Full Exercisability of Option

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Minus: Number of
  Shares Exercisable Prior to

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Termination of
  Employment

  
											

 

Upon termination of
employment by reason of Retirement or Disability, any portion of a Participant’s
Option that is then outstanding shall, to the extent not then exercisable, be
immediately forfeited and canceled in its entirety. To the extent that an
Option is exercisable on the date of a Participant’s Retirement or Disability,
the Option will remain exercisable until the original Expiration Date of the
Option. Notwithstanding the foregoing, if a Participant terminates employment
pursuant to a Company Action under circumstances that also constitute
Retirement for such Participant, then any portion of any Option of the
Participant which becomes exercisable by reason of this Article 12 along with
any portion of any Option of the Participant which is exercisable on the date
of termination of employment shall be exercisable, until the original
Expiration Date of the relevant Option. Upon the death of a Participant, the
outstanding portion of such Participant’s Option shall, to the extent not then
exercisable, become immediately exercisable in full and the Option shall remain
exercisable until the original Expiration Date of the Option.  The Committee or its Delegate may, in its
sole discretion, waive or modify the application of this Article 12 in the case
of any individual Participant.  This
Article 

 14
 

12 applies only to
Options; however the Committee may provide for similar treatment of other forms
of Awards at the time that the Award is granted.

Article 13 — Nonassignability/Deferral

(i)    No Award shall be assigned or transferred by
a Participant who is an Employee other than by will or the laws of descent and
distribution, and during the lifetime of the Participant may be exercised only
by such Participant or his or her guardian or legal representative; provided,
however, that an Option granted under the Plan to an Employee may be assigned
or transferred to the extent determined by the Committee and set forth in the
applicable Award Agreement.

(iii)  To the extent permitted by the Deferral Plan,
a Participant may elect to have all or a portion of any Award deliverable under
this Plan credited to the deferred compensation account of such Participant
under the Deferral Plan to be held in, respectively, the Company Shares and
cash portions of such account.

Article 14 — Change in Control Provisions

Notwithstanding any other
provision of the plan to the contrary, but, with respect to Non-Employee
Directors, subject to Article 19, unless the Committee shall determine
otherwise at the time of grant with respect to a particular Award, in the event
of a Change in Control any Options and Stock Appreciation Rights outstanding as
of the date such Change in Control is determined to have occurred, and which
are not then exercisable and vested, shall become fully exercisable and vested
to the full extent of the original grant and any Restricted Stock and Other
Stock Unit Awards which are not then vested shall become vested and
non-forfeitable to the full extent of the original grant.  If a Change in Control occurs or is to occur
during a Performance Period, the Committee shall determine the extent to which
Performance Awards shall vest or shall be adjusted in accordance with Article
3(c) in the event of a Change in Control. 
This determination shall be made by individuals who are members of the
Incumbent Board, as defined in the definition of Change in Control in Article
1(h).

Article 15 — Reservation of Shares

The Company, during the
term of this Plan, will at all times reserve and keep available, and will seek
or obtain from any regulatory body having jurisdiction any requisite authority
necessary to issue and to sell, the number of Shares that shall be sufficient
to satisfy the requirements of this Plan. The inability of the Company to obtain
from any regulatory body having jurisdiction the authority deemed necessary by
counsel for the Company for the lawful issuance and sale of Shares shall
relieve the Company of any liability in respect of the failure to issue or sell
Shares as to which the requisite authority has not been obtained.

 15
 

 

Article 16 — Taxes

Where permitted by the
Committee and set forth in the applicable Award Agreement, a Participant may
request that the Company satisfy any applicable taxes in connection with an
Award by withholding from payment to the Participant Shares (at minimum
statutory rates only), or the Participant may deliver Shares (whether through
actual delivery or attestation of sufficient ownership) to the Company to
satisfy those obligations,  In addition,
the Company and any Subsidiary shall have the right to condition the grant or
exercise of any Award on a Participant’s payment of any applicable amounts
required by a governmental agency to be withheld from payment to the
Participant or paid or deducted by the Company or a Subsidiary in connection
with an Award (“withholding tax”).  The
Company and any Subsidiary shall also have the right to deduct any withholding
tax from a Participant’s other compensation or to make any other arrangements
to satisfy withholding tax obligations, including arrangements with one or more
brokerage firms pursuant to cashless exercise procedures.  The Company and any Subsidiary shall further
have the right to deduct from any payment under an Award under the Plan or from
a Participant’s other compensation any tax or social insurance payment imposed
on the Company or Subsidiary in connection with such Award.

Article 17 — Employees Based Outside of the
United States

Notwithstanding any
provision of the Plan to the contrary, in order to foster and promote
achievement of the purposes of the Plan or to comply with the provisions of
laws in other countries in which the Company and its Subsidiaries operate or
have Employees, the Committee or its Delegate, in its sole discretion, shall
have the power and authority to (1) determine which Employees that are subject
to the tax, employment and securities laws of nations other than the United
States are eligible to participate in the Plan, (2) modify the terms and
conditions of any Awards granted to such Employees (including the grant of
Restricted Stock, Stock Appreciation Rights or some other comparable form of
award (“Substitute Award”) in lieu of Options), and (3) establish subplans,
modified Option exercise procedures and other terms and procedures to the
extent such actions may be necessary or advisable; provided, however,
that the Committee may not grant such Awards that do not comply with the
limitations of Article 3.  Any subplans
established under this Article 17 shall be attached to this Plan as
Appendices.  The terms of this Plan
applicable to Options shall apply with like effect to Stock Appreciation
Rights, Restricted Stock Awards, Performance Awards, Other Stock Unit Awards
and Substitute Awards to the extent legally permissible.

Article 18 — Rights to Continued Employment
or Directorship

Neither this Plan nor any Award shall be construed as giving any person
the right to be retained in the employ of the Company or any Subsidiary.  No Participant shall have any claim to be
granted any Award under the Plan or to include any Award or its value in any
form of severance or similar pay, or in any benefit plan or program which by
its terms does not specifically include the value of the Award.  There is no obligation of uniformity of
treatment of Participants under the Plan. 
This Plan is of limited duration and creates no ongoing obligation of
the Company to provide any future benefit of similar nature or value.  Nothing in the Plan shall be deemed to

 16

create any obligation on the part of the Board or the Company to
nominate any Director for reelection by the Company’s shareholders or to limit
the rights of the shareholders to remove any Director.

Article 19 — Non-Employee Director Awards

Notwithstanding
any provision in the Plan to the contrary, the following terms shall apply with
respect to Awards granted to Non-Employee Directors under the Plan:

(a)          Inaugural Grants

Non-employee
Directors may receive such inaugural grants of Awards in the form of Shares,
Restricted Stock or Options upon commencement of service on the Board as the
Committee shall determine.

(b)          Retainer.

	
   

  	
  (i)

  	
  Commencing with
  the Annual Term beginning March 1, 2004, each Participant will receive fifty
  percent (50%) of his or her Retainer for each Annual Term in the form of a
  Stock Retainer, Restricted Stock or Option, as determined by the Committee,
  and may elect to receive all or any portion of the remaining fifty percent
  (50%) of such Retainer in the form of either a Stock Retainer or in cash;
  provided, that, to the extent deemed permissible by the Committee, each
  Non-Employee Director may elect to receive in lieu of any or all of any
  amount to be paid as a Stock Retainer a payment in the form of an Option for the
  number of Shares determined pursuant to Article 19(c). Any such election
  shall be filed on a form prescribed by the Committee for this purpose and
  such election (or failure to elect) shall be irrevocable as of the last date
  by which such election was due to be filed with the Company.

  
	
   

  	
   

  	
   

  
	
   

  	
  (ii)

  	
  If any
  Non-Employee Director fails to notify the Secretary of the Company in writing
  by December 31 of the preceding Annual Term of the desired form of payment of
  the Retainer for the next Annual Term, then such Participant shall be deemed
  to have elected a Stock Retainer for fifty percent (50%) of the value of such
  Retainer, with the remaining 50% in cash

  
	
   

  	
   

  	
   

  
	
   

  	
  (iii)

  	
  Any Shares constituting a Stock Retainer shall be payable
  automatically on March 1 of each Annual Term (or, if March 1 is not a
  Business Day, on the next succeeding Business Day), commencing March 1, 2004.
  Payments for the cash portion, if any, of the Annual Retainer shall be made
  on the same day. A Participant’s Stock Retainer shall consist of the largest
  number of whole Shares having a Fair Market Value, as of the date of payment,
  equal to the portion of the Retainer to be paid in Shares. The Fair Market
  Value of any fractional share shall be paid in cash.

  

 

 17
 

 

	
  

  	
  (iv)

  	
  This Article 19
  shall apply to any person who becomes a Non-Employee Director Participant
  other than at the beginning of an Annual Term (or the immediately preceding
  Annual Meeting) with respect to the Retainer determined by the Committee to
  be payable for such portion of such Annual Term which follows his or her
  appointment to the Board. Such person shall make the election prescribed by
  Article 19(b)(i) no later than the 30th day following the effective date of
  his or her appointment to the Board. The payment date for any cash portion of
  the Retainer and the date of grant for any Option or Stock Retainer shall be
  the first Business Day which occurs at least fifteen (15) calendar days after
  receipt by the Company of such election.

  

 

(c)           Options.

	
  

  	
  (i)

  	
  In the event
  that the Committee determines that a Non-Employee Director may elect to
  receive payment of all or any portion of the Retainer in the form of an
  Option, an Option shall be granted, on the terms and conditions described in
  this Plan, to purchase the largest number of whole Shares obtained by
  applying the following formula:

  

 

 

	
  

  	
  Number
  of

  	
  Multiplier
  X

  	
  Dollar Amount of
  Retainer to be paid as an Option

  	
   

  	
   

  
	
   

  	
  Shares =

  	
   

  	
  Fair Market Value of a Share on March 1*

  

 

	
   

  	
  *or, if March 1 is not a Business Day, on the
  next succeeding Business Day.

  
	
   

  	
   

  
	
   

  	
  “Multiplier” shall be a number (but need not be a
  whole number) to be determined by the Committee in its discretion in order to
  provide that any grant to a Director is equitable under the circumstances,
  including without limitation, prior grants awarded to such Director and
  grants awarded to other Directors; provided, however, that the Multiplier
  shall not be less than 1 nor greater than 5.

  
	
   

  	
   

  
	
   

  	
  The value of any fractional share shall be paid in
  cash.

  
	
   

  	
   

  
	
   

  	
  (ii)

  	
  Options shall be subject to the terms and conditions set forth in
  this Plan and to such additional terms and conditions, not inconsistent with
  the provi­sions of this Plan, as the Committee shall deem desirable.

  
	
   

  	
   

  	
   

  
	
   

  	
  (iii)

  	
  The exercise price per Share
  under an Op­tion shall be the Fair Market Value of a Share on the date of
  grant, subject to adjustment as prescribed in Article 3(b).

  
	
   

  	
   

  	
   

  
	
   

  	
  (iv)

  	
  Options shall be vested and
  non-forfeitable on the Grant Date and be fully exercisable on the earliest of
  (i) the date which is six (6) months after the Grant 

  

 

 18
 

 

	
  

  	
  Date, (ii) the occurrence of
  a Change in Control and (iii) the death of a Participant (any of the
  foregoing the “Exercise Date”).

  
	
   

  	
   

  
	
   

  	
  (v)

  	
  Except as provided in this
  Article 19(c)(v) or as otherwise determined by the Committee and set forth in
  the applicable Award Agreement, an Option is not transferable other than by
  will or the laws of descent and distribution, and during the lifetime of the
  Non-Employee Director, may be exercise only by such Non-Employee Director or
  his or her guardian or legal representative. Notwithstanding the foregoing,
  an Award may be transferred by the Non-Employee Director, in accordance with
  rules established by the Company, to one or more members of the Non-Employee
  Director’s immediate family, to a partnership of which the only partners are
  members of such immediate family or to a trust established by the
  Non-Employee Director for the benefit of one or more members of such
  immediate family (each such transferee a “Permitted Transferee”). For
  purposes of this Article 19, “immediate family” means a Non-Employee
  Director’s spouse, parents, children, grandchildren and spouses of children
  and grandchildren (including adopted children and grandchildren, as the case
  may be). A Permitted Transferee may not further transfer the Award. An Award
  transferred pursuant to this Article 19 shall remain subject to all of the
  provisions of the Plan and any Award Agreement with respect to such Award and
  may not be exercised by a Permitted Transferee unless and until all legal or
  regulatory approvals, listings, registrations, qualifications or other
  clearances as determined by the Company to be required or appropriate have been
  obtained.

  
	
   

  	
   

  	
   

  
	
   

  	
  (vi)

  	
  A Non-Employee Director may,
  in accordance with procedures established by the Company, designate one or
  more beneficiaries to receive all of his or her rights to any unexercised
  Award and may change or revoke such designation at any time. In the event of
  the death of the Non-Employee Director, any Award or portion thereof which is
  subject to such a designation shall be exercisable (to the extent such
  designation is determined by the Company to be valid, effective and
  enforceable) by the designated person or persons in accordance with this Plan
  and any Award Agreement. Such determination by the Company shall be final and
  binding on all Persons, and the Company shall have no liability with respect
  to any Person with respect to such determination.

  
	
   

  	
   

  	
   

  
	
   

  	
  (vii)

  	
  Any Option may be exercised by the Participant in whole or in part at
  any time on or after the Exercise Date and before the expiration of such
  Option. The Participant shall make payment of the Option price in cash or in
  Shares (whether through actual delivery or attestation of sufficient
  ownership) with a Fair Market Value
  equivalent to the exercise price for all of the Shares to be purchased upon
  exercise of the Option. Subject to the other provisions of the Plan
  and any applicable Award Agreement, if permitted by the Committee, applicable
  accounting rules and applicable law, the Company may withhold Shares as
  payment of the exercise price for any Option.

  

 

 19
 

Article
20 — Amendment of Plan

The Board may amend the
Plan at any time and from time to time. 
The Board may, at any time or from time to time, suspend or terminate
this Plan in whole or in part.

No such amendment,
suspension or termination of the Plan may, however, impair any Award granted
prior to such amendment, suspension or termination, without the written consent
of the affected Participant.

Shareholder approval of
amendments to the Plan will be obtained where required to comply with
applicable law and New York Stock Exchange regulations.

Article 21 — Term of Plan

The Plan shall become
effective upon approval of the Plan by the stockholders of the Company (the “Effective
Date”).

The Plan shall terminate
on October 1, 2013 or at such earlier date as may be determined by the Board of
Directors.  Termination of the Plan,
however, shall not affect the rights of Participants under Awards previously
granted to them, and all unexpired Awards shall continue in force and operation
after termination of the Plan except as they may lapse or be terminated
pursuant to this Plan.

Article 22 — Code Section 162(m) Provisions

(a)  Notwithstanding any other provision of this
Plan, if the Committee deter­mines at the time Restricted Stock, a Performance
Award or an Other Stock Unit Award is granted to a Participant that such
Participant is, or may be as of the end of the tax year for which the Company
would claim a tax deduction in connection with such Award, a Covered Em­ployee,
then the Committee may provide that this Article 22 is applicable to such Award
under such terms as the Committee shall determine.  Notwithstanding any provision of the Plan
other than Article 3(b), no Participant may receive, in any 36-month period
during the Term beginning with the Effective Date, Awards with respect to more
than, in each case in the aggregate, (i) 1,500,000 Shares, (ii) $15 million in
cash, other securities of the Company or other forms of property, or (iii)
Options or Stock Appreciation Rights on more than 5,000,000 Shares.

(b) If an Award, other
than an Option or Stock Appreciation Right with an exercise price not less than
100% of the Fair Market Value of a Share on the date of grant, is subject to
this Article 22, then the grant of cash, Shares or other property shall be
subject to the Company attaining specified levels of one or any combination of
the following for the Performance Period: 
Net Income; net cash provided by operating activities; earnings per
Share from continuing 

 20
 

operations; operating
income; revenues; gross margin; return on operating assets; return on equity;
economic value added; stock price appreciation; total shareholder return
(measured in terms of stock price appreciation and dividend growth); or cost
control, of the Company or the Subsidiary or division of the Company for or
within which the Covered Employee is primarily employed (collectively, the “Performance
Goals”).  The Committee shall establish
the Performance Goals within 90 days following the date of commencement of the
applicable Performance Period, or by such earlier time as is prescribed by
Section 162(m) of the Code or the regulations thereunder in order for the level
to be considered “pre-established.” The Committee, may, in its discretion,
reduce the amount of any Award subject to this Article 22 based on such
criteria as it shall determine, including but not limited to individual merit.

(c)  Notwithstanding any contrary provision of the
Plan other than Article 14, the Committee may not adjust upwards the amount
payable pursuant to any Award subject to this Article 22, nor may it waive the
achievement of the applicable Performance Goal contained in Article 22(b),
except in the case of the death or disability of a Participant.

(d)  Prior to the payment of any Award subject to
this Article 22, the Committee shall certify in writing that the applicable
Performance Goal applicable to such Award was met.

(e)  The Committee shall have the power to impose
such other restrictions on Awards subject to this Article 22 as it may deem
necessary or appropriate to en­sure that such Awards satisfy all requirements
for “performance-based compensa­tion” within the mean­ing of Section
162(m)(4)(C) of the Code, the regulations promulgated thereunder, and any
successors thereto.

Article 23 — Form of Shares and Restricted
Stock Awards

Shares issued or
delivered under the Plan and any Restricted Stock Award may be evi­denced in
such manner as the Committee in its sole discretion shall deem appropri­ate,
including, without limitation, book-entry registration or issuance of a stock
certificate or certificates. In the event any stock certificate is issued in
respect of a Restricted Stock Award, such certificate shall be regis­tered in
the name of the Participant, and shall bear an appropriate legend referring to
the terms, conditions, and restrictions ap­plicable to such Award.  All shares delivered under the Plan shall be subject to such stop-transfer orders
and other restrictions as the Company may deem advisable under the rules,
regulations, and other requirements of the Securities and Ex­change Commission,
any stock exchange upon which the Shares are then listed, and any applicable
Federal or state securities law, and the Company may cause a legend or leg­ends
to be put on any such certificates to make appropri­ate reference to such
restrictions.

Article 24 — Postponement of Issuance and
Delivery

The issuance or delivery of any Shares under this Plan may be postponed
by the Company for such period as may be required to comply with any applicable
requirements under Federal securities laws, any applicable listing requirements
of any national securities exchange, and requirements under any other law or
regulation applicable to the issuance or delivery of such Shares, and the
Company shall not be obligated to issue or deliver any Shares if the issuance 

 21
 

or delivery of such Shares shall constitute a violation of any
provision of any law or of any regulation of any governmental authority or any
national securities exchange.

Article 25 —
Severability

If any provision of this Plan is or becomes or is deemed invalid,
illegal or unenforce­able in any jurisdiction, or would disqualify the Plan or
any Award under any law deemed applicable by the Company, such provision shall
be construed or deemed amended to conform to applicable laws or if it cannot be
construed or ­deemed amended without, in the determination of the Company,
materially altering the intent of the Plan, it shall be stricken and the
remainder of the Plan shall remain in full force and effect.

Article 26 — Governing Law

The Plan and the validity
and construction of any Awards granted hereunder shall be governed by the laws
of the State of Delaware without regard to principles of conflicts of law.

IN WITNESS WHEREOF, the Company has caused this
Plan, as amended, to be executed effective as of the 3rd day of May, 2007.

	
  AVAYA INC.

  
	
   

  
	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
  Roger Gaston

  
	
   

  	
  Senior Vice
  President — Global Human Resources

  
	
   

  
	
   

  
	
  Attest:

  	
   

  	
   

  
	
   

  	
  Eric Sherbet

  
	
   

  	
  Vice President —
  Law, Corporate and Securities

  
	
   

  	
  & Corporate
  Secretary

  

 

 22Exhibit
4.1

May 2, 2007

	
  To:

  	
   

  	
  Holders of MedImmune, Inc.

  
	
   

  	
   

  	
  1.375% Convertible Senior Notes due 2011 and

  
	
   

  	
   

  	
  1.625% Convertible Senior Notes due 2013

  
	
   

  	
   

  	
   

  
	
  ,

  	
   

  	
  The Bank of New York

  
	
   

  	
   

  	
  as Trustee and Conversion Agent

  
	
   

  	
   

  	
  101 Barclay Street

  
	
   

  	
   

  	
  Floor 8 West

  
	
   

  	
   

  	
  New York, NY 10286

  
	
   

  	
   

  	
  Attention: Corporate Trust Administration

  
	
   

  	
   

  	
   

  
	
  Re:

  	
   

  	
  Notice of Convertibility and

  
	
   

  	
   

  	
  Make-Whole Fundamental Change

  

 

Reference is hereby made
to the Indenture, dated June 28, 2006, between MedImmune, Inc., a Delaware
corporation (the “Company”), and The Bank of New York, a New York
banking corporation (the “Trustee”), relating to the Company’s 1.375%
Convertible Senior Notes due 2011 (the “2011 Notes”), and the Indenture,
dated June 28, 2006, between the Company and the Trustee, relating to the
Company’s 1.625% Convertible Senior Notes due 2013 (the “2013 Notes”
and, together with the 2011 Notes, the “Notes”) (such indentures,
collectively, the “Indentures”). 
Capitalized terms used in this notice without definition have the
respective meanings ascribed to them in the Indentures.  You may request a copy of the Indenture by
calling the Company at (301) 398-0000 or mailing a request to the Company at
One MedImmune Way Gaithersburg, Maryland 20878, Attention: General Counsel.  In addition, copies of the Indentures were
included as exhibits to the Company’s Current report on Form 8-K, filed with
the Securities and Exchange Commission (the “SEC”) on June 5, 2006,
which is available on the SEC’s website at www.sec.gov.

On April 22, 2007, the
Company entered into an Agreement and Plan of Merger (the “Merger Agreement”)
with AstraZeneca PLC, a public limited company incorporated under the laws of
England and Wales (“AstraZeneca”), and AstraZeneca Biopharmaceuticals
Inc., a Delaware corporation and an indirect wholly owned subsidiary of
AstraZeneca (“AstraZeneca Biopharmaceuticals”).

Pursuant and subject to
the Merger Agreement, AstraZeneca Biopharmaceuticals has agreed to commence a
tender offer (the “Tender Offer”) to acquire all of the outstanding
shares of the Company’s common stock, par value $0.01 per share (the “Common
Stock”) at a cash purchase price of $58.00 per share (the “Offer Price”).  Pursuant to the Merger Agreement, as soon as
practicable after the consummation of the Tender Offer and subject to the
satisfaction or waiver of certain conditions set forth in the Merger Agreement,
AstraZeneca Biopharmaceuticals will merge with and into the Company (the “Merger”)
and the Company will become an indirect wholly owned subsidiary of
AstraZeneca.  At the effective time of
the Merger (the “Merger 

Effective Time”),
any shares of Common Stock of the Company remaining outstanding after the
Tender Offer, other than shares held by AstraZeneca, the Company or their
respective subsidiaries or by stockholders who have validly exercised their
appraisal rights under Delaware law, will be converted into the right to
receive the Offer Price.

NOTICE OF
CONVERTIBILITY OF THE NOTES

In accordance with
Sections 10.01(A)(iv), 10.01(C) and 10.14(D) of the Indentures, notice is
hereby given that a Fundamental Change and a Make-Whole Fundamental Change will
occur upon the consummation of the Merger. 
The Company currently anticipates that the Merger Effective Time will
occur on June 16, 2007, but the Company is unable to give any assurances as to
the actual date on which the Merger will occur, if at all.  Accordingly, pursuant to Sections
10.01(A)(iv), 10.01(C) and 10.14(D) of the Indentures, Holders may surrender
securities for conversion at any time during the period (the “Make-Whole
Convertibility Period”) that:

·                  begins on, and
includes, May 2, 2007, the date that is 45 calendar days prior to the “anticipated
effective date” of the Merger; and

·                  ends on, and
includes, the later of:

–                 the
date that is 30 Business Days after the Merger Effective Time, which the
Company will announce no later than the third Business Day after the Merger
Effective Time; and

–                 the
Fundamental Change Repurchase Date, which the Company will announce within 20
Business Days after the Merger Effective Time in accordance with Section
3.02(B) of the Indentures.

Holders that surrender
their Notes for conversion will receive, in exchange for their Notes, cash and,
if applicable, shares of Common Stock in accordance with the applicable
Indenture. However, in accordance with Section 10.11 of the Indentures, from
and after the Merger Effective Time, the Notes will be convertible solely into cash and will no longer
be potentially convertible in part into shares of Common Stock.  The Conversion Rate in effect on May 2, 2007
is 29.9679 shares of Common Stock per $1,000 principal amount of Notes.
However, Holders that convert their Notes during the Make-Whole Convertibility
Period may in some circumstances be entitled to an increased Conversion Rate as
explained below under the heading “Notice of Make-Whole Fundamental Change and
Increase in the Conversion Rate.”

NOTICE OF
MAKE-WHOLE FUNDAMENTAL 

CHANGE AND INCREASE IN THE CONVERSION RATE

Because a Make-Whole
Fundamental Change will occur upon the consummation of the Merger, the
Conversion Rate applicable to the Notes that are surrendered for conversion
during the Make-Whole Convertibility Period will be increased pursuant to
Section 10.14 of the Indentures if, but only if, the Merger is
consummated.  Therefore,
a Holder that surrenders Notes for conversion
during the Make-Whole Convertibility Period will not be entitled to this
increase in the Conversion Rate if the Merger is not consummated.  Because the Merger is subject to certain conditions,
including the successful completion of the Tender Offer that is itself
conditioned on the occurrence of various events, the Merger may not occur.  Accordingly, 

Holders
that convert Notes on or after May 2, 2007 but before we announce the consummation
of the Merger bear the risk that they may not be entitled to this increased
Conversion Rate. 
If the Merger occurs, then we will mail a notice of, and publicly
announce, its consummation no later than the third Business Day after the
Merger Effective Time.  This notice will
state the Merger Effective Time and the amount of the increase in the
Conversion Rate that applies to Notes surrendered for conversion during the
Make-Whole Convertibility Period.

The increase in the
Conversion Rate will be determined based on the Merger Effective Time, which is
the “Effective Date” of the Make-Whole Fundamental Change for purposes of the
Indenture, and the Applicable Price, which is deemed to be the Offer
Price.  As explained above, the “anticipated
effective date” of the consummation of the Merger is June 16, 2007.  If the Merger Effective Time were to occur on
June 16, 2007, then in accordance with Section 10.14 of the Indentures, the
increase in the Conversion Rate applicable to Notes surrendered during the Make-Whole
Convertibility Period would be 0.9835 shares of Common Stock per $1,000
principal amount of Notes, with respect to the 2011 Notes, and 1.5075 shares of
Common Stock per $1,000 principal amount of Notes, with respect to the 2013
Notes.  Thus, if the Merger Effective
Time were to occur on June 16, 2007, the Conversion Rate for the Notes that are
converted during the Make-Whole Convertibility Period would be 30.9514 shares
of Common Stock for each $1,000 principal amount of Notes, in the case of the 2011
Notes, and 31.4754 shares of Common Stock for each $1,000 principal amount of
Notes, in the case of the 2013 Notes, based on, in each case, the Conversion
Rate in effect as of May 2, 2007 of 29.9679 shares of Common Stock per $1,000
principal amount of Notes.  If the Merger
Effective Time were to occur after June 16, 2007 (but before July 15, 2007),
then the Conversion Rate applicable to Notes surrendered during the Make-Whole
Convertibility Period would decrease by approximately 0.000188 shares of Common
Stock per day per $1,000 principal amount of Notes, with respect to the 2011
Notes, and 0.000052 shares of Common Stock per day per $1,000 principal amount
of Notes, with respect to the 2013 Notes.

Holders
should be aware that the Principal Return and amount of Net Shares to be
received upon conversion (the “Conversion Value”) depends in part on the
Volume-Weighted Average Price of the Common Stock for each Trading Day during
the applicable Cash Settlement Averaging Period, which Volume-Weighted Average Price
prior to the Merger Effective Time may be less than the Offer Price.  In accordance with Section 10.11 of the
Indentures,  the Daily Conversion Value
and Daily Net Shares will be calculated based on the value of the Reference
Property (i.e., an amount of cash equal to the Offer Price) instead of the
Volume-Weighted Average Price per share of Common Stock. Accordingly, if the
Merger Effective Time occurs, the Conversion Value may be greater for the Notes
converted after the Merger Effective Time than for Notes converted prior
thereto.

Without limiting the
foregoing, if the Merger Effective Time occurs and Holders fail to convert
their Notes during the Make-Whole Convertibility Period, Holders of Notes then
outstanding will be entitled, notwithstanding the expiration of the Make-Whole
Convertibility Period, to convert their Notes. 
However, Holders will not be entitled to any increase in the Conversion
Rate pursuant to Section 10.14 of the Indenture in respect of such Notes so
converted, unless such conversion occurs during the Make-Whole Convertibility
Period.

Please refer to the Indentures
for a more complete description of the increase in the Conversion Rate
applicable in connection with Make-Whole Fundamental Changes.

CONVERSION
PROCEDURES

Procedures for Conversion

A Holder may convert a
portion of a Note, but only if that portion is an integral multiple of $1,000
in principal amount.

The Company will pay any
documentary, stamp or similar issue or transfer tax or duty due on the issue of
shares of Common Stock, if any, upon conversion of a Note.  However, a Holder that converts a Note must
pay any such tax or duty which is due because such shares are issued in a name
other than such Holder’s name.

As described below, the
procedures to be followed by Holders to exercise the conversion privilege
described in this Notice depend on whether their Notes are in certificated form
or are a Global Security.

Securities held in Certificated
Form

To convert a Note that is
held in certificated form, the Holder must:

·                  complete and
sign a Conversion Notice (a copy of which is attached hereto or which can be
found on the back of the Security), with an appropriate signature guarantee;

·                  surrender the
Note to the Conversion Agent;

·                  furnish
appropriate endorsements and transfer documents if required by the Registrar or
Conversion Agent;

·                  pay the amount
of interest, if any, the Holder must pay in accordance with the applicable
Indenture (see “Interest Payments” below); and

·                  pay any tax or
duty if required pursuant to the applicable Indenture.

Global Securities

To convert a beneficial
interest in a Note that is a Global Security, the Holder must, in addition to
complying with any other rules and procedures of The Depository Trust Company
(the “DTC”):

·                  cause there to
be completed and delivered an appropriate instruction form for conversion, in
accordance with the rules and procedures of DTC;

·                  cause there to
be delivered to the Conversion Agent, through the facilities of DTC, in
accordance with the rules and procedures of DTC, the interest in the Global
Security to be converted;

·                  pay the amount
of interest, if any, the Holder must pay in accordance with the applicable
Indenture (see “Interest Payments” below); and

·                  pay any tax or
duty if required pursuant to the applicable Indenture.

Interest Payments

If a Holder surrenders a
Note for conversion after the close of business on the record date for the
payment of an installment of interest and prior to the related interest payment
date, then, notwithstanding such conversion, the interest payable with respect
to such Note on such interest payment date will be paid, on such interest
payment date, to the Holder of record of such Note at the close of business on
such record date.  However, the Holder
who surrenders the Note for conversion during this period must pay to the
Conversion Agent, upon surrender of the Note, an amount equal to the interest
payable on such interest payment date on the portion of the Note being
converted, unless either:

·                  the Holder
surrenders the note for conversion after the close of business on the record
date immediately preceding the final maturity date of the Note;

·                  the Company has
specified a Fundamental Change Repurchase Date that is after such record date
and on or before such interest payment date; or

·                  to the extent of
any overdue interest, if any overdue interest exists at the time of conversion
with respect to such Note.

The 2011 Notes and 2013
Notes bear interest at an annual rate of 1.375% and 1.625%, respectively,
payable semi-annually, computed on the basis of a 360-day year of twelve 30-day
months.  The interest payment dates for
the Notes are January 15 and July 15 of each year, and the corresponding record
dates are the immediately preceding January 1 and July 1, respectively.

Withdrawal of Purchase Notice

If a Holder has delivered
a Purchase Notice in accordance with the applicable Indenture electing to
exercise its Fundamental Change Repurchase Right to require the Company to
repurchase its Notes, then the Holder will not be permitted to convert those
Notes unless the Holder duly withdraws that Purchase Notice in accordance with
the Indenture.

Taxpayer Identification
Information

Each Holder converting
Notes must provide such Holder’s correct Taxpayer Identification Number, which
generally is such Holder’s Social Security Number or federal Employer
Identification Number, and certain other information, on the Substitute Form
W-9, which is attached hereto, or, alternatively, to establish another basis
for exemption from backup withholding. 
In addition, a Holder must cross out item (2) in the Certification box
on the Substitute Form W-9 if the Holder is subject to backup withholding.  Failure to provide the correct information on
the form may subject the Holder to a $50 penalty imposed by the Internal
Revenue Service and tax backup withholding of 28% on the payments made to the
Holder or to the payee with respect to Notes.

The Conversion Agent is: The Bank
of New York

The Trustee is acting as
the Registrar and Conversion Agent, and the address and telephone number of the
Trustee are as follows:

The Bank of New York

101 Barclay Street

Floor 8 West

New York, NY 10286

Attention: Corporate
Trust Administration

Phone: (212) 815-5360

 

Please refer to the Indentures
for a more complete description of the convertibility of the Notes, the
consideration due upon conversion and when such consideration must be paid by
the Company.

WHERE YOU
CAN FIND ADDITIONAL INFORMATION

The Company files annual,
quarterly and current reports, proxy statements and other information with the
SEC. These SEC filings are available to the public over the Internet at the SEC’s
website at www.sec.gov.  You may also read and copy any document the
Company files with the SEC at the SEC’s Public Reference Room at 100 F Street,
N.E., Room 1580, Washington, D.C. 20549 or obtain copies of these documents at
prescribed rates by writing to the SEC. 
Please call the SEC at 1-800-SEC-0330 for further information on the
operation of its Public Reference Room.

The documents listed
below (as they may be amended from time to time) contain important information
about the Company and the Notes, and Holders should review these documents
carefully before determining whether or not to surrender Notes for purchase by
the Company or to convert their Notes as described in this notice.

·                  the Company’s
annual report on Form 10-K for the year ended December 31, 2006, filed with the
SEC on February 27, 2007, as amended by the Amendment No. 1 to the Company’s
Form 10-K, filed with the SEC on April 30, 2007 (file no. 000-19131);

·                  the Company’s
quarterly report on Form 10-Q for the quarter ended March 31, 2007, filed with
the SEC on April 30, 2007 (file no. 000-19131);

·                  the Company’s
current reports on Form 8-K, filed with the SEC on April 3, 2007, April 12,
2007 and April 23, 2007 (file no. 000-19131);

·                  the description
of the Common Stock and related rights set forth in the Company’s registration
statements on Form 8-A filed with the SEC on April 4, 1991 and December 1, 1998
and any documents subsequently filed that amend such description (file no.
000-19131); and

·                  future filings
the Company makes with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the
Securities Exchange Act of 1934, as amended, on or after the date of this
notice.

For more information about
the Tender Offer and the Merger, Holders should review the tender offer
statement on Schedule TO be filed by AstraZeneca Biopharmaceuticals with the
SEC and the Company’s solicitation/recommendation statement on Schedule 14D-9
to be filed by the Company with the SEC. 
A copy of the Merger Agreement is filed as Exhibit 2.1 to the Company’s
Current Report on Form 8-K filed with the SEC on April 23, 2007.

In the event of
conflicting information in the documents referred to above, the information in
the latest filed documents should be considered correct.  Holders should not assume that the
information in this notice or any of the documents referred to above is
accurate as of any date other than the date of the applicable document.

MEDIMMUNE,
INC.

CONVERSION NOTICE

	
  To convert this Security in accordance with the
  Indenture, check the box:   o

  
	
   

  
	
  To convert only part of this Security, state the
  principal amount to be converted (must be in multiples of $1,000):

  
	
   

  
	
  $__________________

  
	
   

  
	
  If you want the stock certificate representing the
  shares of Common Stock, if any, issuable upon conversion made out in another
  person’s name, fill in the form below:

  
	
   

  
	
   

  
	
  (Insert other person’s soc. sec. or tax I.D. no.)

  
	
   

  
	
   

  
	
   

  
	
   

  
	
   

  
	
   

  
	
   

  
	
   

  
	
  (Print or type other person’s name, address and zip
  code)

  
	
   

  
	
   

  

 

	
  Date:______________

  	
  Signature(s):

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (Sign exactly as your name(s) appear(s) on the other
  side of this Security)

  
	
   

  	
   

  	
   

  
	
  Signature(s) guaranteed by:

  	
   

  	
   

  

(All
signatures must be guaranteed by a guarantor institution participating in the
Securities Transfer Agents Medallion Program or in such other guarantee program
acceptable to the Trustee.)

METHOD OF DELIVERY

o   CHECK HERE IF THE SECURITIES ARE BEING
DELIVERED BY BOOK-ENTRY TRANSFER MADE TO THE ACCOUNT MAINTAINED BY THE
CONVERSION AGENT WITH DTC AND COMPLETE THE FOLLOWING:

Name of Surrendering Institution:

DTC Account Number:

Contact Person:

Address:

Telephone (with international dialing code):

Facsimile (with international dialing code):

Date Surrendered:

Transaction Code Number:

______________________________________________________________________________

SPECIAL ISSUANCE INSTRUCTIONS

To be completed ONLY if payments are to be made to DTC
for the account of someone other than the person(s) whose signature appear(s)
within this conversion notice.

Make payment to:

________________________________________________________________

(DTC Account Number)

________________________________________________________________

(Account Party)

 

 

 

	
  PAYOR’S NAME: The Bank of New York, as Trustee and Conversion Agent

  
	
  SUBSTITUTE Form W-9

  	
   

  	
  Part I — PLEASE PROVIDE YOUR 

  	
   

  	
  TIN:

  
	
   

  	
   

  	
  TIN IN THE BOX AT THE RIGHT AND CERTIFY BY SIGNING
  AND DATING BELOW.

  	
   

  	
  Social Security
  Number

  or

  Employer Identification Number

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Payor’s Request for Taxpayer Identification
  Number (“TIN”) and Certification

  	
   

  	
  Part II — For Payees exempt from backup withholding, see the
  Guidelines for Certification of Taxpayer Identification Number on Substitute
  Form W-9 contained in this Letter of Transmittal and complete as instructed
  therein.

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Part III — Certification — Under penalties of perjury, I certify
  that:  

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (1)

  	
   

  	
  The number shown on this form is my correct TIN (or
  I am waiting for a number to be issued to me); and 

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (2)

  	
   

  	
  I am not subject to backup withholding because: (a)
  I am exempt from backup withholding or (b) I have not been notified by the
  Internal Revenue Service (“IRS”) that I am subject to backup withholding as a
  result of a failure to report all interest or dividends or (c) the IRS has
  notified me that I am no longer subject to backup withholding; and  

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (3)

  	
   

  	
  I am a U.S. person (including a U.S. resident
  alien); and

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (4)

  	
   

  	
  All information provided in this form is true,
  correct and complete.

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  SIGNATURE:                                   

  	
   

  	
  DATE:                              

  
	
   

  	
   

  	
   

  	
   

  	
   

  
							

 

Certification
Instructions — You must cross out item (2) of Part III above if you have
been notified by the IRS that you are subject to backup withholding because of
underreporting interest or dividends on your tax return. However, if after
being notified by the IRS that you were subject to backup withholding, you
received another notification from the IRS that you are no longer subject to
backup withholding, do not cross out item (2) of Part III. (Also see the
instructions in the enclosed Guidelines.)

	
  NOTE:

  	
   

  	
  FAILURE TO COMPLETE AND RETURN THIS SUBSTITUTE
  FORM W-9 MAY RESULT IN BACKUP WITHHOLDING OF A PORTION OF ANY REPORTABLE
  PAYMENTS TO YOU. PLEASE REVIEW THE GUIDELINES FOR CERTIFICATION OF TAXPAYER
  IDENTIFICATION NUMBER ON SUBSTITUTE FORM W-9 CONTAINED IN THIS LETTER OF
  TRANSMITTAL FOR ADDITIONAL DETAILS.

  
	
   

  	
   

  	
   

  

YOU MUST
COMPLETE THE FOLLOWING CERTIFICATE IF YOU ARE AWAITING YOUR TIN.

 

	
   

  
	
  CERTIFICATE
  OF AWAITING TAXPAYER IDENTIFICATION NUMBER

  I certify under
  penalties of perjury that a TIN has not been issued to me, and either (a) I
  have mailed or delivered an application to receive a TIN to the appropriate
  IRS Center or Social Security Administration Office or (b) I intend to mail
  or deliver an application in the near future. I understand that if I do not
  provide a TIN by the time of payment, a portion of all reportable payments
  made to me will be withheld.

  Signature:
                                                                   
       Date:                                                    

  
	
   

  

 

GUIDELINES
FOR CERTIFICATION OF TAXPAYER IDENTIFICATION

NUMBER ON SUBSTITUTE FORM W-9

Guidelines for
Determining the Proper Identification Number to Give the Payor. Social Security Numbers have nine digits
separated by two hyphens: i.e. 000-00-0000. Employer Identification Numbers
have nine digits separated by only one
hyphen: i.e. 00-0000000. The table below will help you determine the number to
give the payor.

	
  

  	
   

  	
   

  
	
  For this type of account:

  	
   

  	
  Give
  the 

  SOCIAL SECURITY NUMBER or 

  EMPLOYER IDENTIFICATION NUMBER
  of:

  
	
  1.

  	
   

  	
  Individual

  	
   

  	
  The individual

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  2.

  	
   

  	
  Two or more individuals (joint account)

  	
   

  	
  The actual owner of the account or, if combined funds, the first individual on the account(1)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  3.

  	
   

  	
  Custodian account of a minor (Uniform Gift to Minors Act)

  	
   

  	
  The minor(2)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  4.

  	
  (a)

  	
  The usual revocable savings trust account (grantor is also trustee)

  	
   

  	
  The grantor-trustee(l)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
  (b)

  	
  So-called trust account that is not a legal or valid trust under State law

  	
   

  	
  The actual owner(l)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5.

  	
   

  	
  Sole proprietorship or single-owner LLC not electing
  corporate status on Form 8832

  	
   

  	
  The owner(3)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6.

  	
   

  	
  A valid trust, estate, or pension trust

  	
   

  	
  The legal entity(4)

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  7.

  	
   

  	
  Corporation or LLC electing corporate status on Form
  8832

  	
   

  	
  The corporation

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  8.

  	
   

  	
  Association, club, religious, charitable,
  educational, or other tax-exempt organization

  	
   

  	
  The organization

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  9.

  	
   

  	
  Partnership or multi-member LLC not electing
  corporate status on Form 8832

  	
   

  	
  The partnership

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  10.

  	
   

  	
  A broker or registered nominee

  	
   

  	
  The broker or nominee

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  11.

  	
   

  	
  Account with the Department of Agriculture in the
  name of a public entity (such as a State or local government, school
  district, or prison) that receives agricultural program payments

  	
   

  	
  The public entity

  

 

(1)          List
first and circle the name of the person whose number you furnish. If only one
person on a joint account has a Social Security Number, that person’s Social
Security Number must be furnished.

(2)          Circle
the minor’s name and furnish the minor’s Social Security Number.

(3)          You
must show your individual name, but you may also enter your business or “doing
business as” name. You may either use your
Social Security Number or Employer Identification Number.

(4)          List
first and circle the name of the legal trust, estate, or pension trust. (Do not
furnish the identifying number of the personal representative or trustee unless
the legal entity itself is not designated in the account title)

Note:       If no name is circled when
more than one name is listed, the number will be considered to be that of the
first name listed.

GUIDELINES
FOR CERTIFICATION OF TAXPAYER IDENTIFICATION

NUMBER ON SUBSTITUTE FORM W-9

Obtaining a Number

If you do not have
a Taxpayer Identification Number or you do not know your number, obtain Form
SS-5, Application for a Social Security Card, or Form SS-4, Application for
Employer Identification Number, at an office of the Social Security
Administration office or the Internal Revenue Service, from www.irs.gov or by
calling 1-800-TAX-FORM and apply for a
number.

Payees Exempt from Backup
Withholding

Backup withholding is not required on payments made to the following
payees:

1.               An
organization exempt from tax under Section 501(a), any IRA, or a custodial
account under Section 403(b)(7) if the account satisfies the requirements of
Section 401(f)(2).

2.               The
United States or any of its agencies or instrumentalities.

3.               A
state, the District of Columbia, a possession of the United States, or any of
their political subdivisions or instrumentalities.

4.               A
foreign government or any of its political subdivisions, agencies or
instrumentalities.

5.               An
international organization or any of its agencies, or instrumentalities.

Other payees that may be
exempt from backup withholding include:

6.               A
corporation.

7.               A
financial institution.

8.               A
dealer in securities or commodities required to register in the U.S., the
District of Columbia, or a possession of the U.S.

9.               A
real estate investment trust.

10.         A
common trust fund operated by a bank under Section 584(a).

11.         A
trust exempt from tax under Section 664 or described in Section 4947.

12.         An
entity registered at all times during the tax year under the Investment Company
Act of 1940.

13.         A
foreign central bank of issue.

14.         A
middleman known in the investment community as a nominee or custodian.

15.         A
futures commission merchant registered with the Commodity Futures Trading
Commission.

The chart below
shows types of payments that may be exempt from backup withholding.  The chart applies to the exempt recipients
listed above, 1 through 15.

	
  IF the payment is for

  	
   

  	
  THEN
  the payment is exempt 

  for

  
	
  Interest
  and dividend payments

  	
   

  	
  All
  exempt recipients except for 15

  
	
   

  	
   

  	
   

  
	
  Broker
  Transactions

  	
   

  	
  Exempt
  recipients 1 through 15 except for 11 & 14. Also, a person registered
  under the Investment Advisers Act of 1940 who regularly acts as a broker

  
	
   

  	
   

  	
   

  
	
  Barter
  exchange transactions and patronage dividends

  	
   

  	
  Exempt
  recipients 1 through 5

  
	
   

  	
   

  	
   

  
	
  Payments
  over $600 required to be reported and direct sales over $5,000

  	
   

  	
  Generally,
  exempt recipients 1 through 6 and 13.

  

 

EXEMPT PAYEES DESCRIBED
ABOVE SHOULD FILE SUBSTITUTE FORM W-9 TO AVOID POSSIBLE ERRONEOUS BACKUP
WITHHOLDING. FURNISH YOUR TAXPAYER IDENTIFICATION NUMBER, WRITE “EXEMPT” ON THE
FACE OF THE FORM IN PART II, SIGN AND DATE THE FORM, AND RETURN IT TO THE PAYOR.

Privacy
Act Notice—Section 6109 of the Internal Revenue Code requires most recipients
to give their correct Taxpayer Identification Number to payors who must
report the payments to the IRS. The IRS uses the numbers for identification
purposes and to help verify the accuracy of tax returns. The IRS may also
provide this information to the Department of Justice for civil and criminal
litigation, and to cities, states, the District of Columbia, and U.S.
possessions to carry out their tax laws. We may also disclose this information
to other countries under a tax treaty, to federal and state agencies to enforce
federal nontax criminal laws, or to federal law enforcement and intelligence
agencies to combat terrorism.

Payors must be
given the numbers whether or not recipients are required to file tax returns.
Payors must generally withhold a certain percentage (currently 28%) of taxable
interest, dividend, and certain other payments to a payee who does not furnish
a Taxpayer Identification Number to a payor. Certain penalties may also apply.

Penalties

(1)    Penalty for Failure to
Furnish Taxpayer Identification Number. If you fail to furnish your taxpayer identification number to a
requester, you are subject to a penalty of $50 for each such failure unless
your failure is due to reasonable cause and not to willful neglect.

(2)          Civil Penalty for False
Information with Respect to Withholding. If you make a false statement
with no reasonable basis that results in no
backup withholding, you are subject to a $500 penalty.

(3)          Criminal Penalty for
Falsifying Information. Willfully
falsifying certifications or affirmations may subject you to criminal penalties
including fines and/or imprisonment.

(4)          Misuse of Taxpayer
Identification Numbers. If the
requester discloses or uses taxpayer identification

numbers in violation of federal law, the requester may be subject to civil and
criminal penalties.

FOR
ADDITIONAL INFORMATION CONTACT YOUR TAX ADVISOR OR THE INTERNAL REVENUE
SERVICE.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}]]